Checked.be
Actif
BE 0666.442.557SA
Indigo Diabetes
Bollebergen 2B ·9052 Gent, Belgique· 9 ans d'activité
Secteur: NACE 72109
(72109)
Conclusion
La probabilité de faillite calculée de Indigo Diabetes sur 12 mois est de 0,3% (très faible). L'entreprise est active depuis 2016 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
Sur la base des données du Moniteur belge et de la BCE.
Chiffres clés
| Active | 9 ans |
| Direction | 12 |
| Sites | 1 |
| Publications | 64 |
Probabilité de faillite (12 mois)
0,3%
Très faible
0%0,5%1,5%4%10%≥25%
Secteur à taux de défaillance plus faible
−Forme juridique à risque plus faible
−
Estimation statistique fondée sur des sources publiques — pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
Évaluation du risque
0 / 100
Risque faibleSignaux de confiance
Plus de 3 ans d'activité
Constituée en 2016 — au-delà des 3 premières années statistiquement les plus fragiles.
Aucun incident juridique
Aucune faillite, réorganisation ou administration provisoire au Moniteur belge.
Administrativement en règle
Aucune radiation par le SPF Économie (UBO, comptes, adresse, activité).
Avertissements administratifs
Aucun avertissement administratif
Indicateurs financiers
Comptes en cours de traitement
La BNB a 9 dépôt(s) pour cette entreprise — dernier exercice 2025 (verkort). Les comptes annuels sont en cours de traitement.
Dépôts au registre
| Exercice | Type | Dépôt | Référence |
|---|---|---|---|
| 31-12-2025 | verkort | 21-05-2026 | 2026-00116750 |
| 31-12-2024 | verkort | 23-04-2025 | 2025-00073373 |
| 31-12-2023 | verkort | 15-05-2024 | 2024-00088813 |
| 31-12-2022 | verkort | 23-05-2023 | 2023-00095429 |
| 31-12-2021 | verkort | 05-08-2022 | 2022-20278155 |
| 31-12-2020 | verkort | 27-05-2021 | 2021-15600563 |
| 31-12-2019 | verkort | 19-05-2020 | 2020-12500448 |
| 31-12-2018 | verkort | 22-05-2019 | 2019-14100191 |
| 31-12-2017 | verkort | 23-05-2018 | 2018-13700044 |
Direction & mandats
Dirigeants & mandats actuels
-
Actif30-06-2023 → auj.
-
Actif14-03-2023 → auj.
-
Actif01-07-2022 → auj.
-
Actif25-06-2021 → auj.
-
Dictys BVBAPersonne moraleAdministrateur délégué· repr. perm.: Danaè DelbekeActe Moniteur 17042528 (22-03-2017)Actif22-03-2017 → auj.
-
Actif09-12-2016 → auj.
-
Actif09-12-2016 → auj.
-
Actif09-12-2016 → auj.
-
Participatiemaatschappij VlaanderenPersonne moraleAdministrateur· repr. perm.: LEJEUNE DianeActe Moniteur 17000410 (02-01-2017)Actif09-12-2016 → auj.
-
Actif09-12-2016 → auj.
-
Actif09-12-2016 → auj.
-
Actif09-12-2016 → auj.
Anciens dirigeants (2)
-
KO PAPersonne moraleAdministrateur· repr. perm.: VAN SCHUYLENBERGH Koenraad Frank ClemensActe Moniteur 17000410 (02-01-2017)Ancien— → 09-12-2016
-
Ancien— → 09-12-2016
Historique complet des nominations issu du Moniteur belge. Les représentants permanents sont indiqués pour les administrateurs personnes morales.
Commissaire / réviseur
| Commissaire / réviseur | Numéro IRE/IBR | Période |
|---|---|---|
| BDO BedrijfsrevisorenActif Commissaire · représenté par Thomas Durieux |
— | 09-12-2016 → auj. |
| BDO Bedrijfsrevisoren bvActif Réviseur d'entreprises · représenté par Thomas Durieux |
— | 15-12-2022 → auj. |
Commissaire désigné, issu du Moniteur belge. Le numéro IRE/IBR renvoie au registre de l'Institut des Réviseurs d'Entreprises.
Structure juridique
| NACE primaire | 72109 |
| Forme juridique | SA(014) |
| Date de constitution | 17-11-2016 |
| Status | Actif |
| Code postal | 9052 |
Connexions & réseau
Structure de groupe
Société mère · 1 filiale · 1 site
Contrôle→
Société mère · 45 filiales · 1 site
Contrôle→
Connexions réseau
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Administrateur personne morale commun
→
Connexions dérivées de dirigeants, adresses, actionnaires et structures de groupe communs au Moniteur belge.
Unités d'établissement
Indigo Diabetes
depuis 20162.259.029.040
Sites physiques enregistrés à la Banque-Carrefour des Entreprises (BCE).
Empreinte immobilière
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active — pas un registre de propriété.
Flandre
1
(100%)
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 44082B0103/00E000 | Flandre | 6 306 m² | 1 · 1 934 m² | 20,0 m · 5 ét. |
Méthodologie
via le siège social : 1
1 des 1 parcelles avec correspondance d'adresse exacte ; les autres sont indicatives.
Liaison sur la base des adresses — ceci ne constitue pas une preuve de propriété.
Mises à jour
Une seule chronologie de tout ce qui est arrivé à cette entreprise — publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
2026
21-05-2026
Dépôt BNB
Comptes annuels déposés
15-04-2026
Acte du Moniteur
Changement d'administrateurs
15-04-2026
Acte du Moniteur
Changement d'administrateurs
2025
23-04-2025
Dépôt BNB
Comptes annuels déposés
2024
15-05-2024
Dépôt BNB
Comptes annuels déposés
04-04-2024
Acte du Moniteur
Changement d'administrateurs
04-04-2024
Acte du Moniteur
Modification des statuts
04-04-2024
Acte du Moniteur
Changement d'administrateurs
04-04-2024
Acte du Moniteur
Capital & actions
04-04-2024
Acte du Moniteur
Capital & actions
04-04-2024
Acte du Moniteur
Capital & actions
04-04-2024
Acte du Moniteur
Changement d'administrateurs
04-04-2024
Acte du Moniteur
Modification des statuts
25-03-2024
Acte du Moniteur
Changement d'administrateurs
25-03-2024
Acte du Moniteur
Changement d'administrateurs
2023
26-06-2023
Acte du Moniteur
Changement d'administrateurs
26-06-2023
Acte du Moniteur
Changement d'administrateurs
23-06-2023
Acte du Moniteur
Changement d'administrateurs
23-06-2023
Acte du Moniteur
Changement d'administrateurs
23-05-2023
Dépôt BNB
Comptes annuels déposés
30-03-2023
Acte du Moniteur
Changement d'administrateurs
30-03-2023
Acte du Moniteur
Changement d'administrateurs
2022
21-12-2022
Acte du Moniteur
Capital & actions
21-12-2022
Acte du Moniteur
Capital & actions
21-12-2022
Acte du Moniteur
Modification des statuts
21-12-2022
Acte du Moniteur
Divers
21-12-2022
Acte du Moniteur
Modification des statuts
21-12-2022
Acte du Moniteur
Capital & actions
19-09-2022
Acte du Moniteur
Capital & actions
19-09-2022
Acte du Moniteur
Modification des statuts
19-09-2022
Acte du Moniteur
Changement d'administrateurs
19-09-2022
Acte du Moniteur
Capital & actions
19-09-2022
Acte du Moniteur
Modification des statuts
19-09-2022
Acte du Moniteur
Changement d'administrateurs
05-08-2022
Dépôt BNB
Comptes annuels déposés
2021
20-09-2021
Acte du Moniteur
Changement d'administrateurs
20-09-2021
Acte du Moniteur
Changement d'administrateurs
28-06-2021
Acte du Moniteur
Capital & actions
28-06-2021
Acte du Moniteur
Capital & actions
25-06-2021
Acte du Moniteur
Changement d'administrateurs
25-06-2021
Acte du Moniteur
Changement d'administrateurs
27-05-2021
Dépôt BNB
Comptes annuels déposés
2020
03-11-2020
Acte du Moniteur
Changement d'administrateurs
03-11-2020
Acte du Moniteur
Changement d'administrateurs
28-07-2020
Acte du Moniteur
Changement d'administrateurs
28-07-2020
Acte du Moniteur
Changement d'administrateurs
28-07-2020
Acte du Moniteur
Capital & actions
28-07-2020
Acte du Moniteur
Modification des statuts
28-07-2020
Acte du Moniteur
Capital & actions
28-07-2020
Acte du Moniteur
Modification des statuts
19-05-2020
Dépôt BNB
Comptes annuels déposés
05-05-2020
Acte du Moniteur
Changement d'administrateurs
05-05-2020
Acte du Moniteur
Changement d'administrateurs
2019
22-05-2019
Dépôt BNB
Comptes annuels déposés
2018
22-10-2018
Acte du Moniteur
Changement de siège
22-10-2018
Acte du Moniteur
Changement de siège
22-10-2018
Acte du Moniteur
Modification des statuts
22-10-2018
Acte du Moniteur
Modification des statuts
18-07-2018
Acte du Moniteur
Capital & actions
18-07-2018
Acte du Moniteur
Capital & actions
23-05-2018
Dépôt BNB
Comptes annuels déposés
2017
22-03-2017
Acte du Moniteur
Changement d'administrateurs
22-03-2017
Acte du Moniteur
Changement d'administrateurs
02-01-2017
Acte du Moniteur
Changement de siège
02-01-2017
Acte du Moniteur
Changement d'administrateurs
02-01-2017
Acte du Moniteur
Capital & actions
02-01-2017
Acte du Moniteur
Modification des statuts
02-01-2017
Acte du Moniteur
Changement d'administrateurs
02-01-2017
Acte du Moniteur
Modification des statuts
02-01-2017
Acte du Moniteur
Changement de siège
02-01-2017
Acte du Moniteur
Capital & actions
2016
21-11-2016
Acte du Moniteur
Constitution
21-11-2016
Acte du Moniteur
Constitution
Moniteur belge — actes
Évolution du capital · 16
04-04-2024
v3.2
04-04-2024
v3.2
04-04-2024
Modification du capital
21-12-2022
v3.2
21-12-2022
Modification du capital
21-12-2022
v3.2
19-09-2022
v3.2
19-09-2022
v3.2
28-06-2021
v3.2
28-06-2021
v3.2
28-07-2020
v3.2
28-07-2020
v3.2
18-07-2018
v3.2
18-07-2018
v3.2
02-01-2017
v3.2
Évolution de l'adresse · 4
22-10-2018
Changement de siège
22-10-2018
v3.2
02-01-2017
Changement de siège
02-01-2017
v3.2
Tous les actes · 64
mis à jour il y a 2 mois
2026
15-04-2026 2 démissionnaires rectificatif
- Henricus van Barlingen — Bestuurder
- Paul Moraviec — Bestuurder
Résumé:
24050364
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Henricus van Barlingen",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_cascade",
"subkind": "rectification",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2023-07-12",
"evidence_quote": "De raad van bestuur stelt vast dat het mandaat van Henricus van Barlingen werd be\u00EBindigd per 12 juli 2023 conform de publicatie in de bijlagen bij het Belgisch Staatsblad per nummer 24050364.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Moraviec",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_cascade",
"subkind": "rectification",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-02-12",
"evidence_quote": "De raad van bestuur stelt vast dat het mandaat van Paul Moraviec werd be\u00EBindigd per 12/02/2024.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christoph Michiels",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Meester Christoph Michiels, Meester Tine Bassens, dhr. Nicolas Bosschaerts en iedere medewerker van het kantoor Deloitte Legal - Lawyers, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tine Bassens",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Meester Christoph Michiels, Meester Tine Bassens, dhr. Nicolas Bosschaerts en iedere medewerker van het kantoor Deloitte Legal - Lawyers, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Nicolas Bosschaerts",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Meester Christoph Michiels, Meester Tine Bassens, dhr. Nicolas Bosschaerts en iedere medewerker van het kantoor Deloitte Legal - Lawyers, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": null,
"reason": null,
"subkind": "confirmation",
"via_org": {
"kbo": null,
"name": "Deloitte Legal - Lawyers",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Meester Christoph Michiels, Meester Tine Bassens, dhr. Nicolas Bosschaerts en iedere medewerker van het kantoor Deloitte Legal - Lawyers, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-04-15",
"filing_date": "2026-04-02",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-09-02",
"unanimous": true
}
],
"is_correction": true,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tine Bassens",
"org_rep_person_name": null,
"person_role_at_subject": "Bijzonder gevolmachtigde"
},
"co_filed_documents": [],
"corrected_publication_numac": "24050364"
}15-04-2026 2 démissionnaires
- Henricus van Barlingen — Bestuurder
- Paul Moraviec — Bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Henricus van Barlingen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Moraviec",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}2024
04-04-2024 7 administrateurs nommés
- Françoise Chombar Marie Cyrilla — Bestuurder
- Sofie Silvia Pieter Paula Baeten — Bestuurder
- Charles-Lambert Marie François Ghislain Beauduin — Bestuurder
- Evan Michael Castiglia — Bestuurder
- Danaè Helenè Pschychè Delbeke — Bestuurder
- Manuardeo — Waarnemer
- Vandewiele Group NV — Waarnemer
Notaire:
Frederic HELSEN · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"events": [
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering beslist om tussentijdse kwijting te verlenen aan alle bestuurders voor de uitoefening van hun mandaat tot heden.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Fran\u00E7oise Chombar Marie Cyrilla",
"address": null,
"birth_date": "1962-05-29",
"profession": null,
"birth_place": "Menen"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Sensinnovat BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - Sensinnovat BV, vast vertegenwoordigd door Fran\u00E7oise Chombar Marie Cyrilla, geboren op 29 mei 1962 te Menen;",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sofie Silvia Pieter Paula Baeten",
"address": null,
"birth_date": "1970-03-09",
"profession": null,
"birth_place": "Gent"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Qbic Venture Partners II NV",
"address": null,
"country": null,
"legal_form": "NV"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - Qbic Venture Partners II NV, vast vertegenwoordigd door mevrouw Sofie Silvia Pieter Paula Baeten, geboren op 9 maart 1970 te Gent;",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Charles-Lambert Marie Fran\u00E7ois Ghislain Beauduin",
"address": null,
"birth_date": "1959-06-19",
"profession": null,
"birth_place": "Ukkel"
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - De heer Charles-Lambert Marie Fran\u00E7ois Ghislain Beauduin, geboren op 19 juni 1959 te Ukkel;",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Evan Michael Castiglia",
"address": null,
"birth_date": "1984-01-14",
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Thuja Capital Management B.V",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - Thuja Capital Management B.V, vast vertegenwoordigd door Evan Michael Castiglia,",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dana\u00E8 Helen\u00E8 Pschych\u00E8 Delbeke",
"address": null,
"birth_date": "1975-01-07",
"profession": null,
"birth_place": "Roeselare"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Dictys BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - Dictys BV, vast vertegenwoordigd door mevrouw Dana\u00E8 Helen\u00E8 Pschych\u00E8 Delbeke, geboren op 7 januari 1975 te Roeselare.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vennootschap wordt bestuurd door een raad van bestuur bestaande uit maximaal vijf (5) leden, benoemd door de algemene vergadering, en die als volgt wordt samengesteld: - \u00E9\u00E9n (1) bestuurder zal de CEO van de Vennootschap zijn (de CEO Bestuurder); - \u00E9\u00E9n (1) bestuurder zal benoemd worden op bindende",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "waarnemer",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Manuardeo",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Manuardeo heeft het recht om \u00E9\u00E9n (1) waarnemer bij de raad van bestuur te benoemen.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "waarnemer",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Vandewiele Group NV",
"address": null,
"country": null,
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Vandewiele Group NV heeft het recht om \u00E9\u00E9n (1) waarnemer te benoemen in de raad van bestuur, behalve gedurende de periode waarin \u00E9\u00E9n lid van de raad van bestuur wordt benoemd op voordracht van Vandewiele Group NV.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Frederic HELSEN",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-04-04",
"filing_date": "2024-04-02",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-03-27",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Frederic HELSEN",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"de geco\u00F6rdineerde tekst van statuten",
"een aanwezigheidslijst",
"vijf volmachten",
"het verslag van het bestuursorgaan overeenkomstig artikel 7:179, \u00A71 juncto 7:191 en 7:193 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld in toepassing van 7:228 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld overeenkomstig artikel 7:180 juncto 7:191 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan met betrekking artikel 7:199 juncto 7:191 van het Wetboek van vennootschappen en verenigingen",
"de verslagen van de commissaris overeenkomstig (i) artikel 7:179, \u00A72, juncto 7:191 en 7:193, (ii) artikel 7:180, tweede lid juncto 7:191, (iii) en artikel 7:155, tweede lid van het Wetboek van vennootschappen en verenigingen"
],
"corrected_publication_numac": null
}04-04-2024 Modification des statuts
Résumé:
v3.2
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}04-04-2024 Changement au sein de l'organe d'administration
Résumé:
v3.2
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}04-04-2024 Augmentation de capital de 4.024.715,66 € à 34.894.137,79 €
- €30.869.422,13 → €34.894.137,79
- Inbreng in geld · Apport en numéraire
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 34894137.79,
"delta_eur": 4024715.66,
"before_eur": 30869422.13,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}04-04-2024 Réduction de capital de 28.036.020,20 € à 6.858.117,59 €
- €34.894.137,79 → €6.858.117,59
- 3 kapitaalbewegingen in deze akte
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 4024715.66,
"currency": "EUR",
"after_eur": 34894137.79,
"delta_eur": 4024715.66,
"before_eur": 30869422.13,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-03-27",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 4.024.715,66 EUR, om het van 30.869.422,13 EUR te brengen op 34.894.137,79 EUR, door inbreng in geld",
"contribution_type": "cash"
},
{
"kind": "capital_decrease",
"amount": 28036020.2,
"currency": "EUR",
"after_eur": 6858117.59,
"delta_eur": -28036020.2,
"before_eur": 34894137.79,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-03-27",
"evidence_quote": "De vergadering beslist het kapitaal, ter aanzuivering van geleden verliezen, in toepassing van artikel 7:210 van het Wetboek van vennootschappen en verenigingen, te verminderen ten belope van 28.036.020,20 EUR, om het te brengen van 34.894.137,79 EUR op 6.858.117,59 EUR, zonder vernietiging van aandelen.",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 78955.9,
"currency": "EUR",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2024-03-27",
"evidence_quote": "De vergadering beslist een machtiging aan het bestuursorgaan toe te kennen in het kader van het toegestaan kapitaal... om het kapitaal in \u00E9\u00E9n of meerdere malen te verhogen... voor een bedrag van achtenzeventigduizend negenhonderdvijfenvijftig euro en negentig cent (EUR 78.955,90)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}04-04-2024 Réduction de capital de 28.036.020,20 € à 6.858.117,59 €
- €34.894.137,79 → €6.858.117,59
- 2 kapitaalbewegingen in deze akte
Notaire:
Frederic HELSEN · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Thuja Capital Healthcare Fund II B.V",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 7523,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Sensinnovat",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 7523,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Powergraph",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 2833,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Manuardeo",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 2893,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Capricorn ICT Arkiv",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 5321,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Fund\u002B",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 17360,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "AvH Growth Capital",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 17360,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Vandewiele Group",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 14467,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Imec.Xpand",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 9579,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "QBIC II FUND ARKIV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 5787,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Capricorn Digital Growth Fund",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 2893,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Thuja Capital Healthcare Fund II BV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Sensinnovat",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "QBIC Arkiv Fund",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Powergraph",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Participatiemaatschappij Vlaanderen",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Manuardeo",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Fidimec",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Capricorn ICT Arkiv",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Fund\u002B",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Vandewiele Group",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "AvH Growth Capital",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Qbic II Fund Arkiv",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Qbic Feeder Fund",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Imec.Xpand",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Capricorn Digital Growth Fund",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 34894137.79,
"delta_eur": 4024715.66,
"before_eur": 30869422.13,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Peter Devlin",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 365714,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Emmet Lydon",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 365714,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "gewone",
"n_new_shares": 8125717,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 4024715.66,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 6858117.59,
"delta_eur": -28036020.2,
"before_eur": 34894137.79,
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"_demoted_from": "capital_increase",
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Frederic HELSEN",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-04-04",
"filing_date": "2024-04-02",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-03-27",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"de geco\u00F6rdineerde tekst van statuten",
"een aanwezigheidslijst",
"vijf volmachten",
"het verslag van het bestuursorgaan overeenkomstig artikel 7:179, \u00A71 juncto 7:191 en 7:193 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld in toepassing van 7:228 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld overeenkomstig artikel 7:180 juncto 7:191 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld overeenkomstig artikel 7:155 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan met betrekking artikel 7:199 juncto 7:191 van het Wetboek van vennootschappen en verenigingen",
"de verslagen van de commissaris overeenkomstig (i) artikel 7:179, \u00A72, juncto 7:191 en 7:193, (ii) artikel 7:180, tweede lid juncto 7:191, (iii) en artikel 7:155, tweede lid van het Wetboek van vennootschappen en verenigingen"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Universiteit Gent",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Katholieke Universiteit Leuven",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Capricorn ICT Arkiv NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Fidimec NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic Arkiv Fund NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Powergraph BV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Participatiemaatschappij Vlaanderen NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Thuja Capital Healthcare Fund II B.V.",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Sensinnovat BV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Manuardeo",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Imec.xpand COMMV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Capricorn Digital Growth Fund NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "AVH Growth Capital NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Fund\u002B NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic Feeder Fund NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Capricorn ICT Arkiv NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Fidimec NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic Arkiv Fund NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Powergraph BV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Participatiemaatschappij Vlaanderen NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Thuja Capital Healthcare Fund II B.V.",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Sensinnovat BV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Manuardeo",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Vandewiele Group NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic II Fund Arkiv NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Peter Devlin",
"role": null,
"n_shares": 365714,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Dana\u00EB Delbeke",
"role": null,
"n_shares": 365714,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Sensinnovat BV",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic Venture Partners II NV",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Charles-Lambert Marie Fran\u00E7ois Ghislain Beauduin",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Thuja Capital Management B.V",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Dictys BV",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Nathalie Van Bruaene",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Dana\u00EB Delbeke",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Fran\u00E7oise Chombar Marie Cyrilla",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Sofie Silvia Pieter Paula Baeten",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Evan Michael Castiglia",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Dana\u00E8 Helen\u00E8 Pschych\u00E8 Delbeke",
"role": null,
"n_shares": null,
"share_class": null
}
],
"share_classes_after": [
{
"n_shares": 21521309,
"class_name": "Gewone Aandelen",
"capital_share_eur": 6858117.59,
"voting_rights_per_share": 1.0
},
{
"n_shares": null,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": null,
"class_name": "A2",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": null,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}04-04-2024 5 administrateurs nommés, 6 démissionnaires
- Sensinnovat BV — Bestuurder
- Qbic Venture Partners II NV — Bestuurder
- Charles-Lambert Marie François Ghislain Beauduin — Bestuurder
- Thuja Capital Management B.V — Bestuurder
- Dictys BV — Bestuurder
- Charles Beauduin — Bestuurder
- An Herremans — Bestuurder
- Evan Castiglia — Bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Charles Beauduin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "An Herremans",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Evan Castiglia",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Halina Novak",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Participatiemaatschappij Vlaanderen NV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dictys BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sensinnovat BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Qbic Venture Partners II NV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Charles-Lambert Marie Fran\u00E7ois Ghislain Beauduin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Thuja Capital Management B.V",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dictys BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}04-04-2024 Modification des statuts
Résumé:
v3.2
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-03-27",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}25-03-2024 Evan Castiglia nommé administrateur
- Evan Castiglia — Bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Evan Castiglia",
"address": null,
"birth_date": null
},
"effective_date": "2023-06-30",
"evidence_quote": "en besluit om (door middel van co\u00F6ptatie) Evan Castiglia als bestuurder van de Vennootschap te benoemen, met ingang van de datum van deze besluiten tot 18 augustus 2028."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}25-03-2024 1 administrateur nommé, 1 démissionnaire
- Evan Castiglia — Bestuurder
- Harrold Van Barlingen — Bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Harrold Van Barlingen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Evan Castiglia",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES"
}
}2023
26-06-2023 1 administrateur nommé, 1 démissionnaire
- Nathalie Van Bruaene — Vertegenwoordiger van bestuurder
- Tine Bekaert — Vertegenwoordiger van bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "vertegenwoordiger van bestuurder",
"person": {
"rrn": null,
"name": "Tine Bekaert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vertegenwoordiger van bestuurder",
"person": {
"rrn": null,
"name": "Nathalie Van Bruaene",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES"
}
}26-06-2023 Changement au sein de l'organe d'administration
Résumé:
v3.2
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}23-06-2023 Thomas Durieux reconduit comme commissaire
- Thomas Durieux — Commissaris
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Thomas Durieux",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BDO Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering beslist om de besloten vennootschap BDO Bedrijfsrevisoren, gevestigd te Da Vincilaan 9 bus E6, 1930 Zaventem, met als vertegenwoordiger de heer Thomas Durieux, te herbenoemen als commissaris voor een mandaat van 3 jaar dat een einde neemt onmiddellijk na de gewone algemene ve"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}23-06-2023 2 administrateurs nommés, 1 démissionnaire
- Halina Novak — Nieuwe investeerder bestuurder
- BDO Bedrijfsrevisoren — Commissaris
- Luc Debruyne — Bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Luc Debruyne",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Nieuwe Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Halina Novak",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BDO Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES"
}
}30-03-2023 Halina Novak nommé administrateur
- Halina Novak — Bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Halina Novak",
"address": null,
"birth_date": null
},
"effective_date": "2023-03-14",
"evidence_quote": "besluit unaniem om (door middel van co\u00F6ptatie) Halina Novak als Nieuwe Investeerder Bestuurder van de Vennootschap te benoemen, met ingang van de datum van deze besluiten tot 18 augustus 2028."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}30-03-2023 1 administrateur nommé, 1 démissionnaire
- Halina Novak — Nieuwe investeerder bestuurder
- Luc Debruyne — Bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Luc Debruyne",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Nieuwe Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Halina Novak",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES"
}
}2022
21-12-2022 Augmentation de capital de 1.500 € à 30.869.422,13 €
- €30.867.922,13 → €30.869.422,13
- Inbreng in geld · Apport en numéraire
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 30869422.13,
"delta_eur": 1500.0,
"before_eur": 30867922.13,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}21-12-2022 Augmentation de capital de 12.123.307,63 € à 30.867.922,13 €
- €18.744.614,50 → €30.867.922,13
- 2 kapitaalbewegingen in deze akte
Notaire:
Frederic HELSEN · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 30867922.13,
"delta_eur": 12123307.63,
"before_eur": 18744614.5,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "THUJA CAPITAL HEALTHCARE FUND II B.V",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "SENSINNOVAT BV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "POWERGRAPH BV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "MANUARDEO",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "CAPRICORN ICT ARKIV NV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "FUND \u002B NV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "AVH Growth Capital",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "VANDEWIELE GROUP NV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "IMEC.XPAND COMM VA",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "QBIC II FUND ARKIV COMM VA",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "CAPRICORN DIGITAL GROWTH FUND NV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Bevoorrechte Klasse B",
"n_new_shares": 565189,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 21.45
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 565189,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 30869422.13,
"delta_eur": 1500.0,
"before_eur": 30867922.13,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Gewone",
"n_new_shares": 15000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.1
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 1500.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 15000,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "loss_absorption_only",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_split",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_buyback",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "agio_incorporation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "withdrawal_redemption",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "merger_share_issue",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "vzw_capital_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Frederic HELSEN",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-12-21",
"filing_date": "2022-12-17",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-12-15",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "BDO Bedrijfsrevisoren BV",
"ibr_number": "22384654",
"mission_type": "quasi_apport",
"individual_name": "Thomas Durieux"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"aanwezigheidslijst",
"12 volmachten",
"de verslagen van de raad van bestuur",
"de verslagen van de commissaris in toepassing van artikelen 7:197, 7:179, 7:180 en 7:155 van het WVV",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 86500,
"class_name": "Gewone Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 41500,
"class_name": "Bevoorrechte Klasse A1 Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 366664,
"class_name": "Bevoorrechte Klasse A2 Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 1871296,
"class_name": "Bevoorrechte Klasse B Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}21-12-2022 Modification des statuts
Résumé:
v3.2
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}21-12-2022 Publication au Moniteur belge — Divers
Résumé:
otherNotaire:
Frederic HELSEN · BrusselÉtude:
BERQUIN NOTARISSEN
Détails techniques
{
"stage": null,
"notary": {
"name": "Frederic HELSEN",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-12-21",
"filing_date": "2022-12-17",
"act_kind_objet": "KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE,"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-12-15",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": {
"summary": "De aandeelhouders verklaren zich vrijwillig van het opstellen van het uitgifteverslag en van het verslag van de commissaris, overeenkomstig artikelen 5:121 en 5:133 van het Wetboek van Vennootschappen en Verenigingen.",
"articles": [
"5:121",
"5:133"
]
},
"restructuring": {
"parties": [
{
"kbo": "0666.442.557",
"name": "Indigo Diabetes NV",
"role": "other",
"address": "Bollebergen 2B bus 5, 9052 Gent",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "THUJA CAPITAL HEALTHCARE FUND II B.V.",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "B.V.",
"is_new_company": false,
"jurisdiction_country": "NL"
},
{
"kbo": null,
"name": "SENSINNOVAT BV",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "B.V.",
"is_new_company": false,
"jurisdiction_country": "NL"
},
{
"kbo": null,
"name": "POWERGRAPH BV",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "B.V.",
"is_new_company": false,
"jurisdiction_country": "NL"
},
{
"kbo": null,
"name": "MANUARDEO",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "CAPRICORN ICT ARKIV NV",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "FUND \u002B NV",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "AVH Growth Capital",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "VANDEWIELE GROUP NV",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "IMEC.XPAND COMM VA",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "QBIC II FUND ARKIV COMM VA",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "CAPRICORN DIGITAL GROWTH FUND NV",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"7:155",
"7:179",
"7:180",
"7:197",
"8.2"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 580189,
"real_estate_included": false,
"patrimony_description": "De kapitaalverhoging vindt plaats door inbreng in natura van opeisbare schuldvorderingen door aandeelhouders, en door inbreng in geld. De inbreng in natura omvat schuldvorderingen ten laste van de vennootschap, waarvan de waarde wordt vastgesteld op basis van waarderingsmethodes en wordt uitgebracht in Bevoorrechte Klasse B Aandelen. De inbreng in geld is voor 1.500 EUR, uitgegeven in 15.000 Gewon",
"equity_transferred_eur": 12123307.63,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Deloitte Legal \u2013 Lawyers",
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van Indigo Diabetes NV, gehouden op 15 december 2022, besliste een kapitaalverhoging in natura van 12.123.307,63 EUR door inbreng van schuldvorderingen door aandeelhouders, met uitgifte van 565.189 Bevoorrechte Klasse B Aandelen. Daarnaast werd een kapitaalverhoging in geld van 1.500 EUR besloten, met uitgifte van 15.000 Gewone Aandelen. De statuten werden gewijzigd om het nieuwe kapitaal van 30.869.422,13 EUR te reflecteren. Verder werd een materi\u00EBle fout in een vorige publicatie rechtgezet, waarbij 43.635 ESOP Warrants werden vernietigd, en 38.604 nieuwe ",
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"aanwezigheidslijst",
"12 volmachten",
"verslagen van de raad van bestuur en commissaris (art. 7:197, 7:179, 7:180, 7:155 WVV)",
"geco\u00F6rdineerde tekst van statuten"
],
"detected_real_type": "other",
"referenced_correction": {
"prior_pub_date": "2022-09-19",
"what_corrected": "verwijdering van 43.635 ESOP Warrants die niet correct zijn beschreven in de vorige publicatie; correctie van de oorsprong van de vernietigde warrants naar meerdere optieplannen (2016, 2018, 2018bis, 2020)",
"prior_pub_number": "22358569"
},
"should_reroute_to_category": "capital_shares"
}21-12-2022 Modification des statuts
Résumé:
v3.2
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2022-12-15",
"legal_form_change": false
},
"bedrijfsrevisor": {
"quote": "Conclusies van het verslag van de commissaris de dato 15 december 2022, opgesteld door de besloten vennootschap \u201CBDO Bedrijfsrevisoren\u201D, te 9090 Melle, Brusselsesteenweg 92, vertegenwoordigd door Thomas Durieux, in toepassing van de artikelen 7:179, \u00A71, tweede lid en 7: 197, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
"firm_kbo": "0423846546",
"firm_name": "BDO Bedrijfsrevisoren BV",
"ibr_number": null,
"individual_name": "Thomas Durieux"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "TWEE\u00CBNTWINTIGSTE BESLISSING: Volmacht voor de formaliteiten. De vergadering verleent bijzondere volmacht aan de advocaten en medewerkers van \u201CDeloitte Legal \u2013 Lawyers\u201D, woonstkeuze gedaan hebbende te 9051 Gent, Raymonde de Larochelaan 19B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
"holder_kbo": null,
"holder_name": "Deloitte Legal \u2013 Lawyers",
"scope_categories": [
"share_register_update",
"kbo_filing",
"tax_filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}21-12-2022 Augmentation de capital de 12.123.307,63 € à 30.867.922,13 €
- €18.744.614,50 → €30.867.922,13
- 2 kapitaalbewegingen in deze akte
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 12123307.63,
"currency": "EUR",
"after_eur": 30867922.13,
"delta_eur": 12123307.63,
"before_eur": 18744614.5,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-15",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 12.123.307,63 EUR, om het van 18.744.614,50 EUR te brengen op 30.867.922,13 EUR, door uitgifte van 565.189 Bevoorrechte Klasse B Aandelen... De vergadering beslist dat de kapitaalverhoging zal worden verwezenlijkt door de inbreng door i) THUJA CAPITAL HEALTHCARE FUND II B.V , ii) SENSINNOVAT BV, iii) POWERGRAPH BV, iv) MANUARDEO, v) CAPRICORN ICT ARKIV NV, vi) FUND \u002B NV vii) AVH Growth Capital, viii) VANDEWIELE GROUP NV, ix) IMEC.XPAND COMM VA, x) QBIC II FUND ARKIV COMM VA en xi) CAPRICORN DIGITAL GROWTH FUND NV... van zekere, vaststaande en opeisbare schuldvorderingen",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 1500.0,
"currency": "EUR",
"after_eur": 30869422.13,
"delta_eur": 1500.0,
"before_eur": 30867922.13,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-15",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 1.500,00 EUR, om het van 30.867.922,13 EUR te brengen op 30.869.422,13 EUR, door inbreng in geld en met de uitgifte van 15.000 Gewone Aandelen... De vergadering beslist dat er onmiddellijk in geld ingeschreven zal worden op de nieuwe aandelen, tegen de prijs van 0,10 EUR elk en dat op ieder aandeel zal onmiddellijk gestort worden ten belope van 100%.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}19-09-2022 Réduction de capital de 7.228.433,19 € à 18.744.614,50 €
- €25.973.047,69 → €18.744.614,50
- 2 kapitaalbewegingen in deze akte
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 5569320.9,
"currency": "EUR",
"after_eur": 25973047.69,
"delta_eur": 5569320.9,
"before_eur": 20403726.79,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-08-18",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van EUR 5.569.320,90, om het van EUR 20.403.726,79 te brengen op EUR 25.973.047,69, door inbreng in geld",
"contribution_type": "cash"
},
{
"kind": "capital_decrease",
"amount": 7228433.19,
"currency": "EUR",
"after_eur": 18744614.5,
"delta_eur": -7228433.19,
"before_eur": 25973047.69,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-08-18",
"evidence_quote": "De vergadering beslist het kapitaal, ter aanzuivering van geleden verliezen, ... te verminderen ten belope van EUR 7.228.433,19, om het te brengen van EUR 25.973.047,69 op EUR 18.744.614,50",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}19-09-2022 Modification des statuts
Résumé:
v3.2
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2022-08-18",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "De vergadering verleent bijzondere volmacht aan de advocaten en medewerkers van \u0022Deloitte Legal - Lawyers\u0022, woonstkeuze gedaan hebbende te 9051 Gent, Raymonde de Larochelaan 19B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
"holder_kbo": null,
"holder_name": "Deloitte Legal - Lawyers",
"scope_categories": [
"KBO",
"tax",
"filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}19-09-2022 DEBRUYNE Luc Eddy nommé administrateur
- DEBRUYNE Luc Eddy — Bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DEBRUYNE Luc Eddy",
"address": null,
"birth_date": null
},
"effective_date": "2022-07-01",
"evidence_quote": "De vergadering bevestigt dat de heer DEBRYNE Luc met ingang van 1 juli 2022 tot bestuurder werd benoemd krachtens een onderhandse beslissing van de algemene vergadering de dato 27 juli 2022, die echter niet werd neergelegd ter publicatie in de Bijlagen bij het Belgisch Staatsblad."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}19-09-2022 Augmentation de capital de 5.569.320,90 € à 25.973.047,69 €
- €20.403.726,79 → €25.973.047,69
- Inbreng in geld · Apport en numéraire
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 25973047.69,
"delta_eur": 5569320.900000002,
"before_eur": 20403726.79,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}19-09-2022 Modification des statuts
Résumé:
v3.2
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}19-09-2022 2 administrateurs nommés, 2 démissionnaires
- DEBRUYNE Luc Eddy — Bestuurder
- COMPASS — Bestuurder
- VAN DEN BOSSCHE Jan — Bestuurder
- DEBRUYNE Luc Eddy — Bestuurder
Résumé:
v3.2
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VAN DEN BOSSCHE Jan",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DEBRUYNE Luc Eddy",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DEBRUYNE Luc Eddy",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "COMPASS",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}Premiers 30 sur 64 actes
Avis de crédit
Rapport de due diligence IA
Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
Bientôt disponible
Généré par IA sur la base des données Checked ; indicatif, ni conseil juridique ni conseil en investissement.
Données d'entreprise (BCE)
Activités
Fabrication d'instruments et de fournitures à usage médical et dentaire32500Fabrication d’instruments et de fournitures à usage médical et dentaire32500Recherche-développement en autres sciences physiques et naturelles72109Recherche-développement en autres sciences physiques et naturelles72190
Activité principale en évidence.
Noms & noms commerciaux
| Dénomination légaleNL | Indigo Diabetes |
Siège social
Bollebergen 2B bus 5
9052 Gent, Belgique
Données officielles de la Banque-Carrefour des Entreprises (BCE). Disponibles pour toutes les entreprises enregistrées.
Entreprises similaires
ABLYNX
BE 0475.295.446 · Gent
AnimAb
BE 0747.674.614 · Gent
BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL
BE 0475.471.036 · Gent
Confo Therapeutics
BE 0632.474.939 · Gent
DEVGEN
BE 0461.432.562 · Gent